Dyadic International, Inc.

NASDAQ:DYAI

Biotechnology

Healthcare
$1.47 +21.49%

+$0.26 today

Market cap
$53.56M
Beta
1.15
P/E (TTM)
-6.9
EPS (TTM)
-$0.20
52W Low $0.65High $1.55

Volume 0.71M

Average 0.31M

DYAI Sales of Investments

Cash received from selling or redeeming investments.

Dyadic International, Inc.NASDAQ: DYAI

Sales of Investments · Q1 FY2026 · quarter ended Mar 2026

Sales of investments declines year over year

Q1 FY2026 sales of investments of $1.83M fell 5.6% year over year, ahead of the -8.1% change in trailing-twelve-month sales of investments. Sequentially, it rose 37.8% from the prior quarter. Over 3 fiscal years it compounded at -7.0% a year.

Context

  • Sales of investments amounted to 489.7% of revenue in FY2025, up 333.3 pp from a year earlier.
  • Sales of investments increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of -5.6% holds above the trailing-twelve-month pace of -8.1%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.83M+37.8% QoQ
Last fiscal yearDec 2025
$6.03M+10.4% YoY
LTMMar 2026
$5.93M-8.1% YoY
Sales of Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-5.6%——
1 year+10.4%——
3-year CAGR-7.0%——
5-year CAGR——
10-year CAGR——

Sales of Investments history

USD · from the cash flow

Latest · FY2025
6.03M USD
Year-over-year change
+10.4%
4-year CAGR
-22.2%

Sales of Investments vs competitors

How DYAI compares with its peers on the latest reported figures

  • Peers report in different currencies, so sales of investments is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -8.1% is the lowest of 2, against a peer median of +705.9%.
  • Sales of investments amounts to 199.2% of revenue for DYAI, versus a peer median of 0.0%.
DYAI Competitors
Sales of Investments for DYAI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DYAIDyadic International, Inc.LTM Mar 2026$5.93M USD-8.1%-7.0%199.2%
VERUVeru Inc.LTM Mar 2026$3.17M USD+705.9%——
ATHEAlterity Therapeutics LimitedFY2025A$0 AUD——0.0%
MAIAMAIA Biotechnology, Inc.LTM Mar 2026$0 USD———
PYPDPolyPid Ltd.LTM Dec 2025$0 USD———
ANVSAnnovis Bio, Inc.LTM Mar 2026$0 USD———
RNXTRenovoRx, Inc.LTM Mar 2026$0 USD——0.0%
CELUCelularity Inc.LTM Dec 2025$0 USD——0.0%
Peer median (excluding DYAI) —+705.9%—0.0%

Competitors are the stored peer set for DYAI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(13.07M)(9.74M)(6.8M)(5.81M)(7.36M)
Depreciation & Amortization0000(24.17K)
Deferred Income Tax00000
Stock-Based Compensation1.78M1.89M1.24M1.13M930.18K
Change in Working Capital1.19M(321.17K)(143.21K)754.53K660.8K
Accounts Receivables(13.92K)(47.18K)(93.13K)205.26K(857.85K)
Inventory00000
Accounts Payables549.56K(248.13K)(651.17K)(180.18K)314.45K
Other Working Capital652.59K(25.87K)601.09K729.45K1.2M
Other Non-Cash Items(1.18M)83.71K(1.03M)(46.45K)95.6K
Operating Cash Flow(11.28M)(8.08M)(6.73M)(3.97M)(5.7M)
Capital Expenditures000(4)0
Acquisitions (Net)00000
Purchases of Investments(11.28M)(9.87M)(3M)(7.34M)(5.95M)
Sales of Investments16.51M7.5M10.45M5.47M6.03M
Other Investing Activities00000
Investing Cash Flow5.22M(2.37M)7.45M(1.88M)82.09K
Debt Repayment0005.82M0
Common Stock Issued00024.25K4.96M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities1.23M543.59K000
Financing Cash Flow1.23M543.59K05.85M4.96M
Effect of Forex Changes(63.26K)(44.74K)(2.39K)(5.8K)1.94K
Net Change in Cash(4.89M)(9.95M)720.76K(8.28K)(653.25K)
Free Cash Flow(11.28M)(8.08M)(6.73M)(3.97M)(5.7M)

Dyadic International, Inc.

NASDAQ:DYAI

Intrinsic Alpha fair value

Locked

Current Price

$1.47

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.